Intravenous Infusion of Nitroglycerine Leads to Increased Permeability on Dynamic Contrast-Enhanced MR Imaging in Pig Brains

REFERENCES

1. 1.↵
   2. Lichtlen PR

   . The mechanism of action of nitrates, 1988 status [in German]. Z Kardiol 1989;78(suppl 2):3–10; discussion 64–67

   PubMed
2. 2.↵
   2. Dewey M,
   3. Hoffmann H,
   4. Hamm B

   . Multislice CT coronary angiography: effect of sublingual nitroglycerine on the diameter of coronary arteries. Rofo 2006;178:600–04

   CrossRefPubMedWeb of Science
3. 3.↵
   2. Mazzuero G,
   3. Mazzuero A,
   4. Pascariello A

   . Severe acute mountain sickness and suspect high altitude cerebral edema related to nitroglycerin use. High Alt Med Biol 2008;9:241–43

   CrossRefPubMed
4. 4.↵
   2. Bailey DM,
   3. Bärtsch P,
   4. Knauth M, et al

   . Emerging concepts in acute mountain sickness and high-altitude cerebral edema: from the molecular to the morphological. Cell Mol Life Sci 2009;66:3583–94

   CrossRefPubMedWeb of Science
5. 5.↵
   2. Cochand NJ,
   3. Wild M,
   4. Brugniaux JV, et al

   . Sea-level assessment of dynamic cerebral autoregulation predicts susceptibility to acute mountain sickness at high altitude. Stroke 2011;42:3628–30

   Abstract/FREE Full Text
6. 6.↵
   2. Kovacic S,
   3. Petrinec Z,
   4. Matasin Z, et al

   . Increased permeability of the blood-brain barrier following administration of glyceryl trinitrate in common carp (Cyprinus carpio L.). Coll Antropol 2008;32(suppl 1):99–103

   PubMed
7. 7.↵
   2. Tofts PS,
   3. Brix G,
   4. Buckley DL, et al

   . Estimating kinetic parameters from dynamic contrast-enhanced T(1)-weighted MRI of a diffusable tracer: standardized quantities and symbols. J Magn Reson Imaging 1999;10:223–32

   CrossRefPubMedWeb of Science
8. 8.↵
   2. Tofts PS

   . Optimal detection of blood-brain barrier defects with Gd-DTPA MR: the influences of delayed imaging and optimised repetition time. Magn Reson Imaging 1996;14:373–80

   CrossRefPubMed
9. 9.↵
   2. Aviv RI,
   3. Huynh T,
   4. Huang Y, et al

   . An in vivo, MRI-integrated real-time model of active contrast extravasation in acute intracerebral hemorrhage. AJNR Am J Neuroradiol 2014;35:1693–99

   Abstract/FREE Full Text
10. 10.↵
    2. Niehaus L,
    3. Gottschalk S,
    4. Weber U

    . Effect of drug-induced vasodilatation of basal brain arteries with nitroglycerin on blood flow velocity and volume flow in the middle cerebral artery [in German]. Ultraschall Med 1998;19:225–29

    CrossRefPubMedWeb of Science
11. 11.↵
    2. Siepmann M,
    3. Kirch W

    . Effects of nitroglycerine on cerebral blood flow velocity, quantitative electroencephalogram and cognitive performance. Eur J Clin Invest 2000;30:832–37

    CrossRefPubMedWeb of Science
12. 12.↵
    2. Bednarczyk EM,
    3. Wack DS,
    4. Kassab MY, et al

    . Brain blood flow in the nitroglycerin (GTN) model of migraine: measurement using positron emission tomography and transcranial Doppler. Cephalalgia 2002;22:749–57

    Abstract/FREE Full Text
13. 13.↵
    2. Willmot M,
    3. Ghadami A,
    4. Whysall B, et al

    . Transdermal glyceryl trinitrate lowers blood pressure and maintains cerebral blood flow in recent stroke. Hypertension 2006;47:1209–15

    CrossRef
14. 14.↵
    2. Asghar MS,
    3. Hansen AE,
    4. Pedersen S, et al

    . Pharmacological modulation of the BOLD response: a study of acetazolamide and glyceryl trinitrate in humans. J Magn Reson Imaging 2011;34:921–27

    CrossRefPubMed
15. 15.↵
    2. Kadoi Y,
    3. Saito S,
    4. Morita T, et al

    . The differential effects of prostaglandin E1 and nitroglycerin on regional cerebral oxygenation in anesthetized patients. Anesth Analg 1997;85:1054–59

    PubMed
16. 16.↵
    2. Hare GM

    . Nitroglycerin and cerebral oxygen saturation. Can J Anaesth 2008;55:52–53; author reply 53

    CrossRefPubMed
17. 17.↵
    2. Jia L,
    3. Wong H

    . In vitro and in vivo assessment of cellular permeability and pharmacodynamics of S-nitrosylated captopril, a nitric oxide donor. Br J Pharmacol 2001;134:1697–704

    CrossRefPubMed
18. 18.↵
    2. Abe H

    . Effects of combination of vasodilator drugs and hypertonic solutions on methotrexate distribution into the rat brain. Jpn J Pharmacol 1988;48:373–76

    CrossRefPubMed